n(g)-aminoarginine has been researched along with tcn 201 in 1 studies
| Studies (n(g)-aminoarginine) | Trials (n(g)-aminoarginine) | Recent Studies (post-2010) (n(g)-aminoarginine) | Studies (tcn 201) | Trials (tcn 201) | Recent Studies (post-2010) (tcn 201) |
|---|---|---|---|---|---|
| 21 | 1 | 2 | 30 | 0 | 29 |
| Protein | Taxonomy | n(g)-aminoarginine (IC50) | tcn 201 (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.341 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.341 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.273 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.2197 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.273 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawker, DD; Jansen Labby, K; Mataka, JJ; Silverman, RB; Trippier, PC | 1 |
1 review(s) available for n(g)-aminoarginine and tcn 201
| Article | Year |
|---|---|
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antioxidants; Calcium Channels; Drug Combinations; Drug Design; Humans; Huntington Disease; Neurodegenerative Diseases; Nitric Oxide Synthase Type I; Oxidative Stress; Parkinson Disease; Protein Folding; Protein Structure, Quaternary; Proteostasis Deficiencies; Receptors, N-Methyl-D-Aspartate | 2013 |